New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Research uncovers new path for melanoma detection and treatment

Research uncovers new path for melanoma detection and treatment

byEdith Cowan UniversityLead researcher from Edith Cowan University, Associate Professor Elin Gray. Credit: Edith Cowan UniversityA new way to spot melanoma cells circulating in the blood has th
World medicine December 13,2023
Research uncovers new path for melanoma detection and treatment

Research uncovers new path for melanoma detection and treatment

byEdith Cowan UniversityLead researcher from Edith Cowan University, Associate Professor Elin Gray. Credit: Edith Cowan UniversityA new way to spot melanoma cells circulating in the blood has th
World medicine December 13,2023
New technique predicts which melanoma patients are at risk for cancer recurrence, spread

New technique predicts which melanoma patients are at risk for cancer recurrence, spread

byBrigham and Women's HospitalScanning electron micrograph of human T lymphocyte or T cell. Credit: NIAID/NIHFor most patients, melanoma begins with a small, pigmented spot on their skin tha
World medicine December 13,2023
New technique predicts which melanoma patients are at risk for cancer recurrence, spread

New technique predicts which melanoma patients are at risk for cancer recurrence, spread

byBrigham and Women's HospitalScanning electron micrograph of human T lymphocyte or T cell. Credit: NIAID/NIHFor most patients, melanoma begins with a small, pigmented spot on their skin tha
World medicine December 13,2023
Common blood thinner may double as cancer therapy

Common blood thinner may double as cancer therapy

byColumbia University Irving Medical CenterCredit:Cell Metabolism(2023). DOI: 10.1016/j.cmet.2023.06.014Warfarin, a widely used blood thinner, appears to have potent anti-cancer prop
World medicine December 13,2023
Common blood thinner may double as cancer therapy

Common blood thinner may double as cancer therapy

byColumbia University Irving Medical CenterCredit:Cell Metabolism(2023). DOI: 10.1016/j.cmet.2023.06.014Warfarin, a widely used blood thinner, appears to have potent anti-cancer prop
World medicine December 13,2023
Targeting turncoat immune cells to treat cancer

Targeting turncoat immune cells to treat cancer

byLudwig Institute for Cancer ResearchPing-Chih Ho, associate member of the Lausanne Branch of the Ludwig Institute for Cancer Research. Credit: Ludwig Cancer ResearchA Ludwig Cancer Research st
World medicine December 13,2023
Targeting turncoat immune cells to treat cancer

Targeting turncoat immune cells to treat cancer

byLudwig Institute for Cancer ResearchPing-Chih Ho, associate member of the Lausanne Branch of the Ludwig Institute for Cancer Research. Credit: Ludwig Cancer ResearchA Ludwig Cancer Research st
World medicine December 13,2023
Protein AKAP8 suppresses breast cancer metastasis

Protein AKAP8 suppresses breast cancer metastasis

by Molly Chiu,Baylor College of MedicineCredit: CC0 Public DomainA protein naturally produced in the body has been found to suppress breast cancer metastasis in animal models of human tumors. Re
World medicine December 13,2023
Protein AKAP8 suppresses breast cancer metastasis

Protein AKAP8 suppresses breast cancer metastasis

by Molly Chiu,Baylor College of MedicineCredit: CC0 Public DomainA protein naturally produced in the body has been found to suppress breast cancer metastasis in animal models of human tumors. Re
World medicine December 13,2023
Evaluating cetuximab's effectiveness and toxicity in advanced cutaneous squamous cell skin cancer

Evaluating cetuximab's effectiveness and toxicity in advanced cutaneous squamous cell skin cancer

by Impact Journals LLCProgression-free survival of all 18 patients. Censored patients are indicated by hash marks. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28470A new research pap
World medicine December 13,2023
Evaluating cetuximab's effectiveness and toxicity in advanced cutaneous squamous cell skin cancer

Evaluating cetuximab's effectiveness and toxicity in advanced cutaneous squamous cell skin cancer

by Impact Journals LLCProgression-free survival of all 18 patients. Censored patients are indicated by hash marks. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28470A new research pap
World medicine December 13,2023
'Chromosome shattering': Understanding chromothripsis in human cancer

'Chromosome shattering': Understanding chromothripsis in human cancer

by Vicky Hatch,European Molecular Biology LaboratoryArtist's impression of chromothripsis. Credit: Spencer Phillips/EMBL-EBIResearchers at Harvard Medical School and EMBL-EBI have carried ou
World medicine December 13,2023
'Chromosome shattering': Understanding chromothripsis in human cancer

'Chromosome shattering': Understanding chromothripsis in human cancer

by Vicky Hatch,European Molecular Biology LaboratoryArtist's impression of chromothripsis. Credit: Spencer Phillips/EMBL-EBIResearchers at Harvard Medical School and EMBL-EBI have carried ou
World medicine December 13,2023
Facebook postings by breast cancer patients initially surge, then decline over time

Facebook postings by breast cancer patients initially surge, then decline over time

byUniversity of MinnesotaCredit: RidofranzTransitions in breast cancer care are associated with significant increases in stress and anxiety, and this stress can negatively impact the mental and
World medicine December 13,2023
Facebook postings by breast cancer patients initially surge, then decline over time

Facebook postings by breast cancer patients initially surge, then decline over time

byUniversity of MinnesotaCredit: RidofranzTransitions in breast cancer care are associated with significant increases in stress and anxiety, and this stress can negatively impact the mental and
World medicine December 13,2023
Patients with challenging cancers to benefit from genomic sequencing

Patients with challenging cancers to benefit from genomic sequencing

byUniversity of MelbourneCredit: AI-generated imageMore than 1,000 Victorian cancer patients are set to benefit from real-time genomic testing in the next three years, aiming to improve diagnosi
World medicine December 13,2023
Patients with challenging cancers to benefit from genomic sequencing

Patients with challenging cancers to benefit from genomic sequencing

byUniversity of MelbourneCredit: AI-generated imageMore than 1,000 Victorian cancer patients are set to benefit from real-time genomic testing in the next three years, aiming to improve diagnosi
World medicine December 13,2023
High BMI may cut overall survival in HER2+, metastatic breast cancer

High BMI may cut overall survival in HER2+, metastatic breast cancer

(HealthDay)—For patients with human epidermal growth factor receptor 2-positive (HER2+) metastatic breast cancer (mBC) treated with pertuzumab and/or trastuzumab emtansine (T-DM1), a body mass index (
World medicine December 13,2023
High BMI may cut overall survival in HER2+, metastatic breast cancer

High BMI may cut overall survival in HER2+, metastatic breast cancer

(HealthDay)—For patients with human epidermal growth factor receptor 2-positive (HER2+) metastatic breast cancer (mBC) treated with pertuzumab and/or trastuzumab emtansine (T-DM1), a body mass index (
World medicine December 13,2023
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com